Evidence map›Paper›PMID 41302623›Full record

ArticleInternational journal of environmental research and public health2025

The Impact of COVID-19 on Racial and Ethnic Disparities in HIV Pre-Exposure Prophylaxis Retention: Data from a Large U.S. Health Care Organization.

Adam C Sukhija-Cohen, Michael F Blasingame, Henna Patani, Marie C D Stoner, Antón Castellanos-Usigli, Allysha C Maragh-Bass

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adam C Sukhija-CohenCenter for Health Systems Research, Sutter Health, 795 El Camino Real, Ames Building, Palo Alto, CA 94301, USA.ORCID 0000-0001-8793-2166
Michael F BlasingameHealthvana, 7162 Beverly Boulevard, Suite 238, Los Angeles, CA 90036, USA.
Henna PataniAIDS Healthcare Foundation, 6255 West Sunset Boulevard, 21st Floor, Los Angeles, CA 90028, USA.ORCID 0000-0003-1101-9308
Marie C D StonerRTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA.ORCID 0000-0002-7189-8669
Antón Castellanos-UsigliAIDS Healthcare Foundation, 6255 West Sunset Boulevard, 21st Floor, Los Angeles, CA 90028, USA.
Allysha C Maragh-BassDuke Global Health Institute, Duke University, 310 Trent Drive, Box 90519, Durham, NC 27710, USA.

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
NIAID NIH HHS P30 AI050410NIMH NIH HHS R25 MH067127
6 · The paper itself

Abstract

Retention in pre-exposure prophylaxis (PrEP) care-defined as receiving a fourth PrEP prescription within 12 months of initiation-remains a major challenge for young adults and individuals minoritized by race and ethnicity in the United States (U.S.), particularly after disruptions in care from the Coronavirus Disease 2019 (COVID-19) pandemic. This study examined changes in PrEP retention before and after COVID-19 among clients ages 18-29 years at AIDS Healthcare Foundation (AHF) Wellness Center clinics across the U.S. We conducted a retrospective analysis of electronic health record (EHR) data from 6047 clients who initiated PrEP between 1 January 2018 and 15 March 2023. Retention was defined as receiving a fourth PrEP prescription within 12 months of initiation. Overall, PrEP initiation increased threefold post-COVID-19, but retention by the fourth prescription declined from 86.2% pre-COVID-19 to 62.6% post-COVID-19 (

Indexed as

COVID-19EthnicityHealthcare DisparitiesHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultAnti-HIV AgentsFemaleHumansMaleRacial GroupsRetrospective StudiesUnited StatesYoung AdultAnti-HIV Agentsethnic disparitiesHIVpre-exposure prophylaxisracial disparitiesretention in care

Identifiers

PMID41302623
PMCPMC12652533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.